内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

PHIBRO ANIMAL HEALTH CORP

PAHC · Nasdaq · CIK 0001069899 · Healthcare · Drug Manufacturers—Specialty & Generic

内部人信号

当前没有活跃买入信号

1 qualifying P purchase group
当前 180 天评分窗口

36 同一窗口内观察到的 Form 4 交易行
19 sales · 16 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2026-05-29 · CORCORAN E THOMAS · $317.7K

为什么没有活跃信号？

买入活动存在
近期买入1 qualifying line group(s)
近期卖出High
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
BENDHEIM JACK; BFI Co., LLCPresident and CEO
▼▼▼▼▼▼▼▼▼○○
David GlennChief Financial Officer
○○○
Miller Larry LeeChief Operating Officer
○○○
Weinstein JudithSee Remarks
○○
Escudero Lisa AnnSee Remarks
○○
Bendheim Daniel MPresident and CEO
○○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方1
买入集中度100%最大买方： CORCORAN E THOMAS · $317.7K
聚集买入 · 15天1 insider峰值活动： 2026-05-29–2026-05-29

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-05-29 · CORCORAN E THOMAS.

近期 Form 4 活动

1买入
116卖出
29其他 Form 4 交易行
51SEC 申报 · 365天
买入1 qualifying P line(s) · 180 days
卖出19 sale line(s) · 仅供背景
其他16 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
1,020,961
上期报告
1,142,218
日均成交量
251,629
回补天数
4.1

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-05-29CORCORAN E THOMAS买入 (P)Class A Common Stock10,000USD 31.77USD 317,700SEC 申报 ↗
2025-02-24CORCORAN E THOMAS买入 (P)Class A Common Stock5,000USD 22.10USD 110,500SEC 申报 ↗
2024-09-04CORCORAN E THOMAS买入 (P)Class A Common Stock5,000USD 20.02USD 100,100SEC 申报 ↗
2021-08-30CORCORAN E THOMAS买入 (P)Class A Common Stock5,000USD 23.68USD 118,400SEC 申报 ↗

Form 4 申报证据

146 transaction lines in the latest 365-day window; 167 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-06Miller Larry Lee奖励／授予 (A)Class A Common Stock3,726USD 0.00USD 0SEC 申报 ↗
2026-08-06David Glenn奖励／授予 (A)Class A Common Stock3,482USD 0.00USD 0SEC 申报 ↗
2026-08-06Weinstein Judith奖励／授予 (A)Class A Common Stock2,478USD 0.00USD 0SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-06Miller Larry Lee奖励／授予 (A)Class A Common Stock3,726USD 0.00USD 0SEC 申报 ↗
2026-08-06David Glenn奖励／授予 (A)Class A Common Stock3,482USD 0.00USD 0SEC 申报 ↗
2026-08-06Weinstein Judith奖励／授予 (A)Class A Common Stock2,478USD 0.00USD 0SEC 申报 ↗
2026-08-06Rodriguez Patrick奖励／授予 (A)Class A Common Stock1,503USD 0.00USD 0SEC 申报 ↗
2026-08-06Miller Larry Lee奖励／授予 (A)Class A Common Stock3,522USD 0.00USD 0SEC 申报 ↗
2026-08-06Escudero Lisa Ann奖励／授予 (A)Class A Common Stock1,547USD 0.00USD 0SEC 申报 ↗
2026-08-06David Glenn奖励／授予 (A)Class A Common Stock3,334USD 0.00USD 0SEC 申报 ↗
2026-08-06Bendheim Daniel M奖励／授予 (A)Class A Common Stock11,699USD 0.00USD 0SEC 申报 ↗
2026-08-06BENDHEIM Jonathan奖励／授予 (A)Class A Common Stock2,716USD 0.00USD 0SEC 申报 ↗
2026-08-06BENDHEIM JACK; BFI Co., LLC奖励／授予 (A)Class A Common Stock12,103USD 0.00USD 0SEC 申报 ↗
2026-08-04Weinstein JudithJ (J)Class A Common Stock472USD 36.60USD 17,275SEC 申报 ↗
2026-08-04Miller Larry LeeJ (J)Class A Common Stock635USD 36.60USD 23,241SEC 申报 ↗
2026-08-04Escudero Lisa AnnJ (J)Class A Common Stock265USD 36.60USD 9,699SEC 申报 ↗
2026-08-04David GlennJ (J)Class A Common Stock840USD 36.60USD 30,744SEC 申报 ↗
2026-08-04Bendheim Daniel MJ (J)Class A Common Stock486USD 36.60USD 17,788SEC 申报 ↗
2026-08-04BENDHEIM JACK; BFI Co., LLCJ (J)Class A Common Stock2,303USD 36.60USD 84,290SEC 申报 ↗
2026-05-29CORCORAN E THOMAS买入 (P)Class A Common Stock10,000USD 31.77USD 317,700SEC 申报 ↗
2026-05-07BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock4,528USD 48.49USD 219,561SEC 申报 ↗
2026-05-06BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 57.37USD 403,883SEC 申报 ↗
2026-05-05BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 55.80USD 392,836SEC 申报 ↗
2026-04-30BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 52.77USD 371,483SEC 申报 ↗
2026-04-29BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 52.92USD 372,557SEC 申报 ↗
2026-04-28BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 55.91USD 393,579SEC 申报 ↗
2026-04-23BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 54.10USD 380,859SEC 申报 ↗
2026-04-22BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 54.29USD 382,202SEC 申报 ↗
2026-04-21BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 55.98USD 394,104SEC 申报 ↗
2026-04-16BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 54.64USD 384,694SEC 申报 ↗
2026-04-16BENDHEIM JACK; BFI Co., LLCC (C)Class A Common Stock100,000USD 0.00USD 0SEC 申报 ↗
2026-04-15BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 56.96USD 401,012SEC 申报 ↗
2026-04-14BENDHEIM JACK; BFI Co., LLC卖出 (S)Class A Common Stock7,040USD 59.08USD 415,896SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码PAHC
CIK0001069899
行业Healthcare
细分行业Drug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史167 transaction lines from 2021-02-08 to 2026-08-06
4 P purchase lines · 123 S sale lines · 40 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.